Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,445.00
+105.00 (2.42%)
At close: Jun 29, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 49.08 billion as of June 29, 2026. Its market cap has decreased by -13.68% in one year.
Market Cap
49.08B
Enterprise Value
40.20B
Revenue
20.98B
Ranking
n/a
PE Ratio
14.71
Stock Price
4,445.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 49.08B, a decrease of -47.05%. That is a compound annual growth rate of -33.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 49.08B | -33.30% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GFI Co., Ltd. | 80.74B |
| BBIA Co., Ltd. | 75.06B |
| NBR Motion | 72.21B |
| Black Yak I&C Co.,Ltd | 70.41B |
| KP Aero Industries | 60.48B |
| GITSN | 58.06B |
| Laseroptek | 47.06B |
| ERCOHS Agricultural Corporation Co.,Ltd | 46.31B |